Structure Therapeutics (GPCR) Earnings Date, Estimates & Call Transcripts $38.65 +0.34 (+0.89%) (As of 07/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 9) -$0.19 Beat By $0.02 Consensus EPS (May. 9) -$0.21 Get Structure Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for GPCR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGPCR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GPCR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> Structure Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.20)($0.19)($0.20)Q2 20242($0.20)($0.20)($0.20)Q3 20242($0.21)($0.19)($0.20)Q4 20242($0.24)($0.20)($0.22)FY 20248($0.85)($0.78)($0.82)Q1 20251($0.24)($0.24)($0.24)Q2 20251($0.23)($0.23)($0.23)Q3 20251($0.22)($0.22)($0.22)Q4 20251($0.24)($0.24)($0.24)FY 20254($0.93)($0.93)($0.93)GPCR Earnings Date and InformationStructure Therapeutics last announced its quarterly earnings results on May 9th, 2024. The reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.02. Structure Therapeutics has generated ($0.77) earnings per share over the last year (($0.77) diluted earnings per share). Earnings for Structure Therapeutics are expected to grow in the coming year, from ($0.94) to ($0.34) per share. Structure Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Structure Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024(Estimated)------- 5/9/2024Q1 2024($0.21)($0.19)+$0.02($0.19)--3/8/2024Q4 2023($0.21)($0.17)+$0.04($0.17)--11/14/2023Q3 2023($0.22)($0.21)+$0.01($0.21)--8/10/2023Q2 2023($0.19)($0.20)($0.01)($0.20)--5/11/2023Q1 2023($0.34)($0.25)+$0.09($0.25)-- Structure Therapeutics Earnings - Frequently Asked Questions When is Structure Therapeutics's earnings date? Structure Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on GPCR's earnings history. Did Structure Therapeutics beat their earnings estimates last quarter? In the previous quarter, Structure Therapeutics (NASDAQ:GPCR) reported ($0.19) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.02. Learn more on analysts' earnings estimate vs. GPCR's actual earnings. How much profit does Structure Therapeutics generate each year? Structure Therapeutics (NASDAQ:GPCR) has a recorded net income of -$89.62 million. GPCR has generated -$0.77 earnings per share over the last four quarters. What is Structure Therapeutics's EPS forecast for next year? Structure Therapeutics's earnings are expected to grow from ($0.94) per share to ($0.34) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Elanco Animal Health Earnings Date Cytokinetics Earnings Date Madrigal Pharmaceuticals Earnings Date Viking Therapeutics Earnings Date Organon & Co. Earnings Date Nuvalent Earnings Date BridgeBio Pharma Earnings Date Apellis Pharmaceuticals Earnings Date Avidity Biosciences Earnings Date Crinetics Pharmaceuticals Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Leading Healthcare Provider Stock Soars on Earnings BeatViking Therapeutics: Pharma Stock Soars on Positive EarningsEarnings Season Sell-Off: Is This Tech Giant a Buy?Pharma Leader Beats on Earnings, But Shares FallSemiconductor Giant Posts Big Earnings Beat, but Shares Stay FlatIs This Industrial Stock a Buy After Recent Earnings Boost?Consumer Staple Stock's Q2 Earnings: Key Surprises and Challenges This page (NASDAQ:GPCR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.